Chest MRI in children: Why bother? by Owrangi, Amir M & Parraga, Grace
Western University 
Scholarship@Western 
Medical Biophysics Publications Medical Biophysics Department 
1-1-2012 
Chest MRI in children: Why bother? 
Amir M Owrangi 
Grace Parraga 
Follow this and additional works at: https://ir.lib.uwo.ca/biophysicspub 
 Part of the Medical Biophysics Commons 
Citation of this paper: 
Owrangi, Amir M and Parraga, Grace, "Chest MRI in children: Why bother?" (2012). Medical Biophysics 
Publications. 149. 
https://ir.lib.uwo.ca/biophysicspub/149 
EDITORIAL
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In this issue of Respirology, Montella and colleagues1
ask this question: How does high-field chest MRI
compare with CT of children with non-cystic fibrosis
(CF) lung disease? In an important extension of the
first description of this study2 where they compared
MRI and CTwith pulmonary functionmeasurements,
the authors evaluated how widely-used chest CT and
almost never-utilized lung MRI compare for diagnos-
tic imaging of chronic lung disease. Here they show
that high-field (3Tesla as compared with the 1.5Tesla
clinical standard) thoracic MRI has high reliability
and good-to-excellent agreementwith CT, definitively
answering the important question at hand; their
results support more widespread and routine use
of MRI in longitudinal monitoring of chronic lung
disease, especially in children as well as further opti-
mization and improvement of lung MRI methods.
Importantly, non-CF lung disease accounts for the
majority of paediatric pulmonary abnormalities3 and
the increasing prevalence and economic burden4
related to chronic respiratory disease shouldmotivate
the research and development of novel MRI methods
for serial and longitudinal imaging.5
X-ray-based high resolution CT (HRCT) still pro-
vides the tool of choice for chest imaging of adults and
children with respiratory disease mainly because of
its short acquisition times, high spatial resolution and
rich information content based on the differential
attenuation of x-rays in the lung tissue and airspaces.
Although HRCT provides a way to display and
qualitatively/quantitatively interpret lung abnormali-
ties, all x-ray basedmethods includingHRCTdeliver a
small but potentially significant radiation dose
to the patient. This limits repeated or longitudinal
imaging, a particular problem for children with
chronic respiratory disorders. To directly address this
limitation, one approach has involved the develop-
ment of low-dose HRCT techniques6 and these have
become a routine part of screening for, and examina-
tion of, lung disease,7 although the radiation risks
are not eliminated. Another approach involves the
development of thoracic MRI—mainly overlooked as
a clinical application, although its diagnostic poten-
tial was recognized nearly two decades ago.8
Conventional proton MRI (1H MRI) is readily
available in most clinical care centres and radiology
departments, however, until now, a number of funda-
mental challenges have limited its use as a clinical
tool for lung imaging. MRI provides exquisite soft
tissue contrast of the brain, abdomen andmusculosk-
eletal system by virtue of its detection of water-bound
protons in slightly different chemical environments.
Proton MRI therefore is understandably dependent
on the proton density of the tissues involved but the
lung has relatively low tissue density (and high gas
density) and is mainly devoid of water. Therefore the
lung has very low proton density—and this is one
reason why thoracic MRI, even when optimized for
the lung, results in an image that resembles a black
hole,9,10 apparently devoid of tissue and morphologi-
cal information. Compounding this, the lung consists
of millions of air-tissue interfaces (on the micrometre
scale) designed to aid in gas exchange and because of
this, the different magnetic environments in the air
and tissue result in so-called magnetic ‘susceptibility
artefacts’. High-field lung MRI susceptibility artefacts
result in transverse relaxation times (T2*) that are
shortened (T2* = 740 ms at 3T), and the practical
implication for imaging is that signal decay is accel-
erated and pulse sequences must be optimized for
faster echo times (on the order of 10–100 ms). Taken
together, low proton density and susceptibility arte-
factsmean that lungMRImust incorporate both short
echo time/acquisition and long acquisition times for
signal averaging and improved signal-to-noise ratios.
Recently there has been a renewed interest in the
clinical potential of thoracic proton MRI stimulated
by cardiac MRI developments11 as well as novel pul-
monary functional MRI using noble gas contrast
agents12 and Fourier-decomposition proton MRI.13,14
Pertinent to the current evaluation is the develop-
ment of the use of ultra-short echo times for lung
structure imaging pioneered by Mayo and Muller8
with recent applications to CF15 and non-CF lung
diseases.16
Here, Montella et al1 utilize a straightforward MRI
protocol, available onmost hospital scanners without
the need for additional programming, enabling a
practical comparison between two clinically available
methods; this is a definite strength of their approach
and speaks to the relevance of their results. Although
future work will likely incorporate optimized pulse
sequences and methods with decreased echo times
(e.g. echo time here was 92 ms and with UTE, echo
time of 12 ms is possible), the current results are very
promising and urge us to continue to develop and test
improved lung structural and functional MRI for
routine clinical use.
Up until recently, the imaging modality of choice
for clinical diagnosis and monitoring of respiratory
disease has unquestionably been x-ray-based HRCT.
Although good agreement between MRI and CT
was observed and reported here, it is clear that lung
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imaging using MRI currently cannot surpass HRCT in
terms of speed, image contrast and content as well as
spatial resolution. In fact, because of the inherent
limitations based on the physics of MRI itself, pulmo-
nary MRI may never replace HRCT for lung disease
diagnoses. However, in recognition of the fact that the
lung is the most radiosensitive organ in the chest17,18
and longitudinal monitoring will increase the risk of
cumulative radiation doses,19 especially in children,
MRI, even without optimization, should be consid-
ered. As shown here, the information derived is
certainly complementary to HRCT and in some lon-
gitudinal applications in chronic disease, is superior
to CT because of its relatively low risk and high infor-
mation content. Certainly, the current study high-
lights the practical diagnostic information available
now using thoracic MRI acquired on conventional
clinical scanners.
Yes, we think chest MRI is definitely worth the
bother, now, and in the future.
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